(2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4,5-dihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2S,3R,4S,5R)-2-acetamido-1,4,5-trihydroxy-6-sulfooxyhexan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid

Term ID

CHEBI:148247

Synonyms

Definition

References

glygen:G20112RE
glytoucan:G20112RE

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4,5-dihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2S,3R,4S,5R)-2-acetamido-1,4,5-trihydroxy-6-sulfooxyhexan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid

Phenotype where environments contain (2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4,5-dihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2S,3R,4S,5R)-2-acetamido-1,4,5-trihydroxy-6-sulfooxyhexan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid

Phenotype modified by environments containing (2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4,5-dihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2S,3R,4S,5R)-2-acetamido-1,4,5-trihydroxy-6-sulfooxyhexan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid

Phenotype affecting (2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4,5-dihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2S,3R,4S,5R)-2-acetamido-1,4,5-trihydroxy-6-sulfooxyhexan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid

Human Disease Model